experimental group:Vaccination + Qi-enhancing immunity

2 trials

Sponsors

China Academy of Chinese Medical Sciences

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

Study on the Mechanism of Yiqi Zengmian Fang and Huashibaidu Granules on New Coronary Pneumonia

RecruitingChiCTR2100050483

China Academy of Chinese Medical SciencesNovel Coronavirus Pneumonia (COVID-19)

Start: 2021-08-25Updated: 2022-05-02

Study on the Mechanism of Yiqi Zengmian Fang and Huashibaidu Granules on New Coronary Pneumonia

RecruitingITMCTR2100005241

China Academy of Chinese Medical SciencesNovel Coronavirus Pneumonia (COVID-19)

Start: 2021-08-25Updated: 2023-02-20